US Stock MarketDetailed Quotes

STRO Sutro Biopharma

Watchlist

3.420
0.0000.00%

Close Apr 26 16:00 ET

3.420
0.0000.00%

Post 16:46 ET

279.64MMarket Cap-1921P/E (TTM)

Sutro Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-3,245.00%-111.62M

158.97%14.07M

-150.87%-33.5M

-879.13%-31.2M

-73.00%-60.99M

104.35%3.55M

-10.58%-23.86M

369.83%65.85M

39.46%-3.19M

-15.86%-35.26M

Net income from continuing operations

10.41%-106.79M

189.80%31.07M

-152.89%-49.28M

-48.10%-38.52M

-27.97%-50.05M

-12.95%-119.2M

9.26%-34.59M

36.94%-19.49M

-322.82%-26.01M

-28.83%-39.11M

Depreciation and amortization

19.79%6.82M

13.29%1.73M

20.93%1.74M

23.91%1.73M

21.70%1.62M

17.46%5.69M

16.20%1.53M

28.62%1.44M

24.73%1.4M

2.79%1.33M

Other non cash items

475.63%16.82M

835.93%7.58M

854.26%7.39M

125.18%1.23M

-20.91%628K

-52.56%2.92M

-55.95%810K

-53.18%774K

-62.46%544K

-34.81%794K

Change In working capital

-132.92%-34.38M

-210.30%-21.58M

-95.32%3.74M

-21.92%7.88M

-367.38%-24.41M

692.54%104.41M

524.68%19.57M

8,546.16%79.98M

354.70%10.09M

70.52%-5.22M

-Change in receivables

-642.15%-28.96M

-571.20%-19.45M

-107.67%-6.63M

99.85%-126K

-458.20%-2.75M

177.46%5.34M

3,429.03%4.13M

2,826.50%86.43M

-4,348.27%-85.99M

146.04%768K

-Change in prepaid assets

103.08%109K

-10.95%-669K

130.35%868K

2,603.07%7.33M

-3,601.89%-7.42M

10.48%-3.54M

-204.87%-603K

-1,107.04%-2.86M

79.60%-293K

106.27%212K

-Change in payables and accrued expense

464.21%30.11M

476.77%24.78M

658.59%4.84M

-19.30%2.69M

-54.13%-2.2M

-37.75%5.34M

5.04%4.3M

-131.62%-867K

51.36%3.34M

-209.09%-1.43M

-Change in other current liabilities

-341.57%-4.59M

-398.78%-1.46M

-396.25%-1.42M

-280.71%-862K

-285.59%-837K

169.60%1.9M

125.98%490K

189.55%480K

316.82%477K

630.59%451K

-Change in other working capital

-132.56%-31.06M

-320.14%-24.78M

289.68%6.08M

-101.26%-1.16M

-114.27%-11.2M

856.15%95.37M

2,259.33%11.25M

-299.75%-3.21M

3,694.21%92.55M

56.88%-5.23M

Cash from discontinued investing activities

Operating cash flow

-3,245.00%-111.62M

158.97%14.07M

-150.87%-33.5M

-879.13%-31.2M

-73.00%-60.99M

104.35%3.55M

-10.58%-23.86M

369.83%65.85M

39.46%-3.19M

-15.86%-35.26M

Investing cash flow

Cash flow from continuing investing activities

88.80%-3.92M

37.93%-23.51M

-46.11%-114.02M

38.07%66.16M

104.51%67.45M

64.01%-35.02M

-282.29%-37.88M

-3,380.69%-78.04M

715.44%47.92M

127.09%32.98M

Net PPE purchase and sale

45.09%-4.32M

57.20%-1.44M

55.56%-328K

27.09%-1.6M

39.34%-942K

48.72%-7.86M

-32.72%-3.37M

85.23%-738K

59.36%-2.2M

34.64%-1.55M

Net investment purchase and sale

101.44%391K

36.07%-22.07M

-47.08%-113.69M

35.21%67.76M

98.04%68.39M

66.86%-27.17M

-248.11%-34.52M

-2,905.77%-77.3M

343.93%50.12M

128.93%34.54M

Net other investing changes

----

0.00%9K

----

Cash from discontinued investing activities

Investing cash flow

88.80%-3.92M

37.93%-23.51M

-46.11%-114.02M

38.07%66.16M

104.51%67.45M

64.01%-35.02M

-282.29%-37.88M

-3,380.69%-78.04M

715.44%47.92M

127.09%32.98M

Financing cash flow

Cash flow from continuing financing activities

184.71%137.55M

-125.57%-3.13M

-119.23%-5.74M

2,409.77%137.66M

1,052.37%8.76M

1,383.81%48.31M

2,315.22%12.22M

2,999.38%29.85M

14,164.10%5.49M

-58.38%760K

Net issuance payments of debt

-33.33%-12.5M

0.00%-3.13M

---3.13M

---9.38M

---3.13M

--0

Net common stock issuance

-78.73%11.97M

--0

-87.81%1.05M

--10.92M

803,957.14%56.27M

219,314.29%15.35M

--32.33M

--8.6M

--0

Proceeds from stock option exercised by employees

25.73%2.37M

--0

37.86%954K

--0

18.97%1.41M

-55.74%1.88M

-99.81%1K

-34.22%692K

-99.56%2K

-46.89%1.19M

Net other financing activities

29,412.74%135.72M

--0

-7,038.00%-3.57M

1,074,807.69%139.74M

-5.87%-451K

53.09%-463K

--0

43.82%-50K

102.65%13K

-4.67%-426K

Cash from discontinued financing activities

Financing cash flow

184.71%137.55M

-125.57%-3.13M

-119.23%-5.74M

2,409.77%137.66M

1,052.37%8.76M

1,383.81%48.31M

2,315.22%12.22M

2,999.38%29.85M

14,164.10%5.49M

-58.38%760K

Net cash flow

Beginning cash position

53.83%48.13M

-15.30%82.71M

195.01%235.97M

112.76%63.34M

53.83%48.13M

-84.89%31.29M

209.23%97.65M

39.68%79.99M

-47.48%29.77M

-84.89%31.29M

Current changes in cash

30.72%22.01M

74.63%-12.57M

-967.65%-153.26M

243.77%172.62M

1,105.82%15.22M

109.58%16.84M

-16,802.73%-49.53M

168.77%17.66M

8,648.08%50.21M

98.99%-1.51M

End cash Position

45.74%70.14M

-15.30%82.71M

195.01%235.97M

112.76%63.34M

53.83%48.13M

209.23%97.65M

39.68%79.99M

-47.48%29.77M

Free cash flow

-2,590.44%-115.93M

146.38%12.63M

-151.95%-33.83M

-508.97%-32.8M

-68.26%-61.93M

95.56%-4.31M

-12.91%-27.23M

321.46%65.12M

49.55%-5.39M

-12.20%-36.81M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-3,245.00%-111.62M	158.97%14.07M	-150.87%-33.5M	-879.13%-31.2M	-73.00%-60.99M	104.35%3.55M	-10.58%-23.86M	369.83%65.85M	39.46%-3.19M	-15.86%-35.26M
Net income from continuing operations	10.41%-106.79M	189.80%31.07M	-152.89%-49.28M	-48.10%-38.52M	-27.97%-50.05M	-12.95%-119.2M	9.26%-34.59M	36.94%-19.49M	-322.82%-26.01M	-28.83%-39.11M
Depreciation and amortization	19.79%6.82M	13.29%1.73M	20.93%1.74M	23.91%1.73M	21.70%1.62M	17.46%5.69M	16.20%1.53M	28.62%1.44M	24.73%1.4M	2.79%1.33M
Other non cash items	475.63%16.82M	835.93%7.58M	854.26%7.39M	125.18%1.23M	-20.91%628K	-52.56%2.92M	-55.95%810K	-53.18%774K	-62.46%544K	-34.81%794K
Change In working capital	-132.92%-34.38M	-210.30%-21.58M	-95.32%3.74M	-21.92%7.88M	-367.38%-24.41M	692.54%104.41M	524.68%19.57M	8,546.16%79.98M	354.70%10.09M	70.52%-5.22M
-Change in receivables	-642.15%-28.96M	-571.20%-19.45M	-107.67%-6.63M	99.85%-126K	-458.20%-2.75M	177.46%5.34M	3,429.03%4.13M	2,826.50%86.43M	-4,348.27%-85.99M	146.04%768K
-Change in prepaid assets	103.08%109K	-10.95%-669K	130.35%868K	2,603.07%7.33M	-3,601.89%-7.42M	10.48%-3.54M	-204.87%-603K	-1,107.04%-2.86M	79.60%-293K	106.27%212K
-Change in payables and accrued expense	464.21%30.11M	476.77%24.78M	658.59%4.84M	-19.30%2.69M	-54.13%-2.2M	-37.75%5.34M	5.04%4.3M	-131.62%-867K	51.36%3.34M	-209.09%-1.43M
-Change in other current liabilities	-341.57%-4.59M	-398.78%-1.46M	-396.25%-1.42M	-280.71%-862K	-285.59%-837K	169.60%1.9M	125.98%490K	189.55%480K	316.82%477K	630.59%451K
-Change in other working capital	-132.56%-31.06M	-320.14%-24.78M	289.68%6.08M	-101.26%-1.16M	-114.27%-11.2M	856.15%95.37M	2,259.33%11.25M	-299.75%-3.21M	3,694.21%92.55M	56.88%-5.23M
Cash from discontinued investing activities
Operating cash flow	-3,245.00%-111.62M	158.97%14.07M	-150.87%-33.5M	-879.13%-31.2M	-73.00%-60.99M	104.35%3.55M	-10.58%-23.86M	369.83%65.85M	39.46%-3.19M	-15.86%-35.26M
Investing cash flow
Cash flow from continuing investing activities	88.80%-3.92M	37.93%-23.51M	-46.11%-114.02M	38.07%66.16M	104.51%67.45M	64.01%-35.02M	-282.29%-37.88M	-3,380.69%-78.04M	715.44%47.92M	127.09%32.98M
Net PPE purchase and sale	45.09%-4.32M	57.20%-1.44M	55.56%-328K	27.09%-1.6M	39.34%-942K	48.72%-7.86M	-32.72%-3.37M	85.23%-738K	59.36%-2.2M	34.64%-1.55M
Net investment purchase and sale	101.44%391K	36.07%-22.07M	-47.08%-113.69M	35.21%67.76M	98.04%68.39M	66.86%-27.17M	-248.11%-34.52M	-2,905.77%-77.3M	343.93%50.12M	128.93%34.54M
Net other investing changes	----	----	----	----	----	0.00%9K	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	88.80%-3.92M	37.93%-23.51M	-46.11%-114.02M	38.07%66.16M	104.51%67.45M	64.01%-35.02M	-282.29%-37.88M	-3,380.69%-78.04M	715.44%47.92M	127.09%32.98M
Financing cash flow
Cash flow from continuing financing activities	184.71%137.55M	-125.57%-3.13M	-119.23%-5.74M	2,409.77%137.66M	1,052.37%8.76M	1,383.81%48.31M	2,315.22%12.22M	2,999.38%29.85M	14,164.10%5.49M	-58.38%760K
Net issuance payments of debt	-33.33%-12.5M	0.00%-3.13M	0.00%-3.13M	0.00%-3.13M	---3.13M	---9.38M	---3.13M	---3.13M	---3.13M	--0
Net common stock issuance	-78.73%11.97M	--0	--0	-87.81%1.05M	--10.92M	803,957.14%56.27M	219,314.29%15.35M	--32.33M	--8.6M	--0
Proceeds from stock option exercised by employees	25.73%2.37M	--0	37.86%954K	--0	18.97%1.41M	-55.74%1.88M	-99.81%1K	-34.22%692K	-99.56%2K	-46.89%1.19M
Net other financing activities	29,412.74%135.72M	--0	-7,038.00%-3.57M	1,074,807.69%139.74M	-5.87%-451K	53.09%-463K	--0	43.82%-50K	102.65%13K	-4.67%-426K
Cash from discontinued financing activities
Financing cash flow	184.71%137.55M	-125.57%-3.13M	-119.23%-5.74M	2,409.77%137.66M	1,052.37%8.76M	1,383.81%48.31M	2,315.22%12.22M	2,999.38%29.85M	14,164.10%5.49M	-58.38%760K
Net cash flow
Beginning cash position	53.83%48.13M	-15.30%82.71M	195.01%235.97M	112.76%63.34M	53.83%48.13M	-84.89%31.29M	209.23%97.65M	39.68%79.99M	-47.48%29.77M	-84.89%31.29M
Current changes in cash	30.72%22.01M	74.63%-12.57M	-967.65%-153.26M	243.77%172.62M	1,105.82%15.22M	109.58%16.84M	-16,802.73%-49.53M	168.77%17.66M	8,648.08%50.21M	98.99%-1.51M
End cash Position	45.74%70.14M	45.74%70.14M	-15.30%82.71M	195.01%235.97M	112.76%63.34M	53.83%48.13M	53.83%48.13M	209.23%97.65M	39.68%79.99M	-47.48%29.77M
Free cash flow	-2,590.44%-115.93M	146.38%12.63M	-151.95%-33.83M	-508.97%-32.8M	-68.26%-61.93M	95.56%-4.31M	-12.91%-27.23M	321.46%65.12M	49.55%-5.39M	-12.20%-36.81M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall